Selarsdi 130 mg/26mL
ustekinumab-aekn · INJECTION, SOLUTION · Teva Pharmaceuticals USA, Inc.
No Recall History
Plain English
Selarsdi is a injection, solution containing ustekinumab-aekn at 130 mg/26mL, taken intravenous. Manufactured by Teva Pharmaceuticals USA, Inc..
Key Facts
- Brand Name
- Selarsdi
- Generic Name
- ustekinumab-aekn
- NDC Code (Product)
51759-708- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Strength
- 130 mg/26mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761343
- Marketing Start
- 03/12/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Selarsdi used for?
Selarsdi contains ustekinumab-aekn. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Selarsdi a controlled substance?
Selarsdi is not classified as a controlled substance by the DEA.
What is the generic name for Selarsdi?
The generic name for Selarsdi is ustekinumab-aekn. There are 5 other brand versions of ustekinumab-aekn.
What is the NDC code for Selarsdi 130 mg/26mL?
The NDC (National Drug Code) for Selarsdi 130 mg/26mL is 51759-708, listed by Teva Pharmaceuticals USA, Inc..